Julien Penders is co-founder of Bloom Technologies, a consumer health company dedicated to helping moms raise healthy happy families, with the vision to leverage the transformational experience of pregnancy and childbirth to drive behavior change towards healthy living for mom, baby, and family. Julien is also Program Director at imec where he leads the wearable healthcare activities for North America. Prior to this position, Julien served as Program Manager at the Holst Centre / imec, where he led the activities on Body Area Networks. Julien has led wearable health projects for market leaders in both the medical and consumer spaces. He has (co-) authored over 60 papers and 7 patents in the field of wearable technologies and connected health. He has been a keynote or invited speakers at multiple public events and conferences, including TEDx and the Creativity World Forum. He is general co-chair for the Wireless Health conference, serves on the IEEE Technical Committee on Biomedical Health Informatics, and sits on the Program Committees for several international conferences. Julien was a 2004/2005 fellow of the Belgian American Educational Foundation. He holds a M.Sc. degree in Systems Engineering from University of Liege, Belgium (2004), and a M.Sc. degree in Biomedical Engineering from Boston University, MA (2006).
Did you know?
Miranda Wang and Jeanny Yao have an uncanny talent for finding value where others see waste. Their plastics upcycling company, Novoloop, just raised an $21m Series A to prove it.
To find the future of food, you may have to look no further than Emeryville, CA, a small city by the San Francisco Bay, where Upside Foods has built a 53,000-square-foot production facility for cultivated meat, the first of its kind.
In a timeless dilemma for new parents, Radhika and her husband Bharath discovered early that their baby daughter was a fussy sleeper. The situation left them tired and frustrated; being effective at work became a challenge.
The question for Sumit Sinha and Mukesh Bansal in February 2019 was which would come first: The funding for their seed round or the sale of their Hyundai hatchbacks.
In December 2021 Prellis raised a $14.5 million Series B and has signed partnerships with pharmaceutical behemoths including Bristol Myers Squibb and Sanofi.
It was 2016, and Chiu Chau was on the ropes. He had pitched nearly 150 venture capital firms. No one would invest. Everyone doubted the startup with the open-source laboratory robot.
Tesh Mbaabu rarely showed up to his freshman computer science class at the University of Nairobi. His classmate Mesongo Sibuti noticed.
Adebayo (“Ade”) Alonge and Amy Kao, co-founders of RxAll had nvented a handheld scanner for detecting counterfeit prescription drugs—an illicit, multibillion-dollar industry that kills an estimated 1 million people annually globally and 100,000 in Africa.